Evidence map›Paper›PMID 35059973›Full record

ArticleMolecular biology reports2022

The complete chloroplast genome sequence of Clerodendranthus spicatus, a medicinal plant for preventing and treating kidney diseases from Lamiaceae family.

Qing Du, Mei Jiang, Sihui Sun, Liqiang Wang, Shengyu Liu, Chuanbei Jiang, Haidong Gao, Haimei Chen, Yong Li, Bin Wang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Qing Du *Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100193, People's Republic of China.ORCID http://orcid.org/0000-0002-0732-3377
Mei Jiang *Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100193, People's Republic of China.ORCID http://orcid.org/0000-0002-8266-7233
Sihui Sun *College of Pharmacy, Xiangnan University, Chenzhou, Hunan, 423000, People's Republic of China.ORCID http://orcid.org/0000-0002-5140-9477
Liqiang WangCollege of Pharmacy, Heze University, Heze, Shandong, 274015, People's Republic of China.ORCID http://orcid.org/0000-0002-8366-7016
Shengyu LiuInstitute of Medical Information & Library, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, People's Republic of China.ORCID http://orcid.org/0000-0002-5262-1744
Chuanbei JiangGenepioneer Biotechnologies Inc., Nanjing, Jiangsu, 210023, People's Republic of China.ORCID http://orcid.org/0000-0003-2607-5011
Haidong GaoGenepioneer Biotechnologies Inc., Nanjing, Jiangsu, 210023, People's Republic of China.ORCID http://orcid.org/0000-0003-2774-5013
Haimei ChenInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100193, People's Republic of China.ORCID http://orcid.org/0000-0001-7100-5915
Yong LiCollege of Pharmacy, Xiangnan University, Chenzhou, Hunan, 423000, People's Republic of China.ORCID http://orcid.org/0000-0003-4945-6503
Bin WangCollege of Pharmacy, Xiangnan University, Chenzhou, Hunan, 423000, People's Republic of China. beinwang@126.com.ORCID http://orcid.org/0000-0002-9939-7030
Chang LiuInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100193, People's Republic of China. cliu6688@yahoo.com.ORCID http://orcid.org/0000-0003-3879-7302
Chinese Academy of Medical Sciences & Peking Union Medical College · CNXiangnan University · CNSingleron Biotechnologies (china) · CNHeze University · CNQilu University of Technology · CNQinghai University · CN

Funding

Hubei Technological Innovation Special Fund 2018SK52001Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College 2021-1-I2M-022National Science Foundation 81872966National Science &Technology Fundamental Resources Investigation Program of China 2018FY100705Natural Science Foundation of Qinghai 2020-ZJ-Y20the Key Scientific Research Projects of Hunan Education Department 20A467
6 · The paper itself

Abstract

backgroundClerodendranthus spicatus (Thunb.) C. Y. Wu ex H. W. Li is one of the most important medicines for the treatment of nephrology in the southeast regions of China. To understand the taxonomic classification of Clerodendranthus species and identify species discrimination markers, we sequenced and characterized its chloroplast genome in the current study. METHODS AND

resultsTotal genomic DNA were isolated from dried leaves of C. spicatus and sequenced using an Illumina sequencing platform. The data were assembled and annotated by the NOVOPlasty software and CpGAVAS2 web service. The complete chloroplast genome of C. spicatus was 152,155 bp, including a large single-copy region of 83,098 bp, a small single-copy region of 17,665 bp, and a pair of inverted repeat regions of 25,696 bp. The Isoleucine codons are the most abundant, accounting for 4.17% of all codons. The codons of AUG, UUA, and AGA demonstrated a high degree of usage bias. Twenty-eight simple sequence repeats, thirty-six tandem repeats, and forty interspersed repeats were identified. The distribution of the specific rps19, ycf1, rpl2, trnH, psbA genes were analyzed. Analysis of the genetic distance of the intergenic spacer regions shows that ndhG-ndhI, accD-psaI, rps15-ycf1, rpl20-clpP, ccsA-ndhD regions have high K2p values. Phylogenetic analysis showed that C. spicatu is closely related to two Lamiaceae species, Tectona grandis, and Glechoma longituba.

conclusionsIn this study, we sequenced and characterized the chloroplast genome of C. spicatus. Phylogenomic analysis has identified species closely related to C. spicatus, which represent potential candidates for the development of drugs improving renal functions.

Indexed as

Genome, ChloroplastKidney DiseasesLamiaceaePlants, MedicinalPhylogenyChloroplast genomeClerodendranthus spicatusCodon usageHypervariable regionPhylogenetic analysis

Identifiers

PMID35059973
OpenAlexW4220692757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.